# EDGAR Filing Document

**Accession Number:** 0001850051
**File Stem:** 0000000000-23-000533
**Filing Date:** 2023-1
**Character Count:** 2808
**Document Hash:** 67ea44b6c774070dc4eb4763c2b4ffad
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000000000-23-000533.hdr.sgml**: 20230215

**ACCESSION NUMBER**: 0000000000-23-000533

**CONFORMED SUBMISSION TYPE**: UPLOAD

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20230118

**FILED FOR**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Intelligent Medicine Acquisition Corp.
- **CENTRAL INDEX KEY:** 0001850051
- **STANDARD INDUSTRIAL CLASSIFICATION:** BLANK CHECKS [6770]
- **IRS NUMBER:** 862283527
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** UPLOAD

**BUSINESS ADDRESS:**
- **STREET 1:** 9001 BURDETTE RD.
- **CITY:** BETHESDA
- **STATE:** MD
- **ZIP:** 20817
- **BUSINESS PHONE:** 202-905-5834

**MAIL ADDRESS:**
- **STREET 1:** 9001 BURDETTE RD.
- **CITY:** BETHESDA
- **STATE:** MD
- **ZIP:** 20817

## Text-Extract

```

United States securities and exchange commission logo

                     January 18, 2023

       Gregory Simon
       Chief Executive Officer
       Intelligent Medicine Acquisition Corp.
       9001 Burdette Rd.
       Bethesda, MD 20817

                                                        Re: Intelligent
Medicine Acquisition Corp.
                                                            Preliminary Proxy
Statement on Schedule 14A
                                                            Filed January 4,
2023
                                                            File No. 001-41024

       Dear Gregory Simon:

              We have completed our review of your filing. We remind you that
the company and its
       management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding
       any review, comments, action or absence of action by the staff.

                     Sincerely,

                     Division of Corporation Finance

                     Office of Real Estate & Construction
       cc:                                              R. William Burns, Esq.

```

### Attached PDF Documents

**Attachment 1:** `filename1`

![img-0.jpeg](img-0.jpeg)

DIVISION OF
CORPORATION FINANCE

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

January 18, 2023

Gregory Simon
Chief Executive Officer
Intelligent Medicine Acquisition Corp.
9001 Burdette Rd.
Bethesda, MD 20817

**Re: Intelligent Medicine Acquisition Corp.**
**Preliminary Proxy Statement on Schedule 14A**
**Filed January 4, 2023**
**File No. 001-41024**

Dear Gregory Simon:

We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.

Sincerely,

Division of Corporation Finance
Office of Real Estate & Construction

cc: R. William Burns, Esq.